INTRODUCTION: Human immunodeficiency virus (HIV)-infected patients in the current treatment era can achieve normal life expectancies but experience a high degree of medical and psychiatric comorbidity. Impaired physical function and pain, often in the context of mood disorders and substance abuse, are common in HIV-infected patients. The objective of this study was to investigate the relationship of pain, a modifiable condition, to functional impairment in HIV-infected patients, independent of mood disorders and substance abuse. METHODS: Participants in a prospective cohort of HIV-infected patients at the University of Alabama at Birmingham were included. Patient-reported outcome measures were used to cross-sectionally assess pain and physical function (EuroQOL), mood disorders (PHQ), and substance abuse (ASSIST). Univariate and multivariable models were built with pain as the principal independent variable of interest and three domains of physical function (mobility, self-care, and usual activities) as outcomes. Covariates included mood, substance abuse, age, race, sex, insurance status, HIV transmission risk factor, and CD4+ T-cell count. RESULTS: Among 1,903 participants, 693 (37%) reported pain; 509 (27%) had a mood disorder; and 157 (8.4%) reported current substance abuse. In multivariable models, pain was independently associated with increased odds of impairment in all three domains of physical function investigated-mobility (aOR 10.5, 95% CI 7.6-14.6), self-care (aOR 4.1, 95% CI 2.2-7.4), and usual activities (aOR 5.4, 95% CI 4.0-7.4). DISCUSSION: Pain was associated with substantially increased odds of impairment in physical function. Pain should be an important consideration in HIV primary care. Interventions to address pain and impaired physical function should be investigated. Wiley Periodicals, Inc.
INTRODUCTION:Human immunodeficiency virus (HIV)-infectedpatients in the current treatment era can achieve normal life expectancies but experience a high degree of medical and psychiatric comorbidity. Impaired physical function and pain, often in the context of mood disorders and substance abuse, are common in HIV-infectedpatients. The objective of this study was to investigate the relationship of pain, a modifiable condition, to functional impairment in HIV-infectedpatients, independent of mood disorders and substance abuse. METHODS:Participants in a prospective cohort of HIV-infectedpatients at the University of Alabama at Birmingham were included. Patient-reported outcome measures were used to cross-sectionally assess pain and physical function (EuroQOL), mood disorders (PHQ), and substance abuse (ASSIST). Univariate and multivariable models were built with pain as the principal independent variable of interest and three domains of physical function (mobility, self-care, and usual activities) as outcomes. Covariates included mood, substance abuse, age, race, sex, insurance status, HIV transmission risk factor, and CD4+ T-cell count. RESULTS: Among 1,903 participants, 693 (37%) reported pain; 509 (27%) had a mood disorder; and 157 (8.4%) reported current substance abuse. In multivariable models, pain was independently associated with increased odds of impairment in all three domains of physical function investigated-mobility (aOR 10.5, 95% CI 7.6-14.6), self-care (aOR 4.1, 95% CI 2.2-7.4), and usual activities (aOR 5.4, 95% CI 4.0-7.4). DISCUSSION: Pain was associated with substantially increased odds of impairment in physical function. Pain should be an important consideration in HIV primary care. Interventions to address pain and impaired physical function should be investigated. Wiley Periodicals, Inc.
Authors: Krisann K Oursler; Joseph L Goulet; Stephen Crystal; Amy C Justice; Kristina Crothers; Adeel A Butt; Maria C Rodriguez-Barradas; Knachelle Favors; David Leaf; Leslie I Katzel; John D Sorkin Journal: AIDS Patient Care STDS Date: 2011-01 Impact factor: 5.078
Authors: Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski Journal: J Pain Date: 2009-02 Impact factor: 5.820
Authors: Claude Ann Mellins; Jennifer F Havens; Cheryl McDonnell; Carolyn Lichtenstein; Karina Uldall; Margaret Chesney; E Karina Santamaria; James Bell Journal: AIDS Care Date: 2009-02
Authors: Bernd Löwe; Kerstin Gräfe; Stephan Zipfel; Robert L Spitzer; Christoph Herrmann-Lingen; Steffen Witte; Wolfgang Herzog Journal: J Psychosom Res Date: 2003-12 Impact factor: 3.006
Authors: Jessica S Merlin; Melonie Walcott; Robert Kerns; Matthew J Bair; Kathryn L Burgio; Janet M Turan Journal: Pain Med Date: 2015-02-03 Impact factor: 3.750
Authors: Michael A Owens; Romy Parker; Rachael L Rainey; Cesar E Gonzalez; Dyan M White; Anooshah E Ata; Jennifer I Okunbor; Sonya L Heath; Jessica S Merlin; Burel R Goodin Journal: J Neurovirol Date: 2018-11-09 Impact factor: 2.643
Authors: Crystal Chapman Lambert; Andrew Westfall; Riddhi Modi; Rivet K Amico; Carol Golin; Jeanne Keruly; Evelyn Byrd Quinlivan; Heidi M Crane; Anne Zinski; Bulent Turan; Janet M Turan; Michael J Mugavero Journal: AIDS Care Date: 2019-06-05
Authors: Jessica S Merlin; Andrew O Westfall; Sonya L Heath; Burel R Goodin; Jesse C Stewart; Robert E Sorge; Jarred Younger Journal: J Acquir Immune Defic Syndr Date: 2017-08-01 Impact factor: 3.731
Authors: Jessica S Merlin; Andrew O Westfall; Eric Chamot; Michael Saag; Melonie Walcott; Christine Ritchie; Stefan Kertesz Journal: AIDS Res Hum Retroviruses Date: 2015-03-12 Impact factor: 2.205
Authors: Kristine M Erlandson; Jennifer A Schrack; Catherine M Jankowski; Todd T Brown; Thomas B Campbell Journal: Curr HIV/AIDS Rep Date: 2014-09 Impact factor: 5.071
Authors: Jessica S Merlin; Dustin Long; William C Becker; Edward R Cachay; Katerina A Christopoulos; Kasey Claborn; Heidi M Crane; E Jennifer Edelman; Richard Harding; Stefan G Kertesz; Jane M Liebschutz; W Christopher Mathews; Michael J Mugavero; Sonia Napravnik; Connall C OʼCleirigh; Michael S Saag; Joanna L Starrels; Robert Gross Journal: J Acquir Immune Defic Syndr Date: 2018-09-01 Impact factor: 3.731